TRAP1与恶性肿瘤的关系及研究进展

doi:10.11904/j.issn.1002-3070.2017.04.016

Abstract

Abstract: Tumor necrosis factor receptor-associated protein 1(TRAP1),also known as HSP75,is a molecular chaperone protein of heat shock protein 90(HSP90)which can be expressed in a variety of human malignant tumor cells.TRAP1 is involved in cell apoptosis,metabolism,intercellular adhesion,movement,invasion and metastasis,and is associated with tumor cell resistance.The latest studies have demonstrated that abnormal expression of TRAP1 was found in the development process of breast cancer,colon cancer,ovarian cancer and other tumors.Further studies have confirmed that TRAP1 plays a key role in the regulation of energy metabolism in tumor cells,by blocking its function can lead to the death of tumor cells,and will not affect the normal cells.As a new target for tumor therapy,TRAP1 is receiving more and more attention.

Key words: TRAP1, Tumor, Molecular mechanism, Therapeutic target

CLC Number:

YUAN Meng,LI Xiaoli. Research progress of the relationship between TRAP1 and malignant tumor[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(4): 371-375.

References

1 Song HY,Dunbar JD,Zhang YX,Donner DB,et al.Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor[J].J Biol Chem,1995,270(8):3574-3581.
2 Sciacovelli M,Guzzo G,Morello V,et al.The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase[J].Cell Metab,2013,17(6):988-999.
3 Skinner SJ,Doonanco KR,Boles RG,et al.Homozygous TRAP1 sequence variant in a child with Leigh syndrome and normal kidneys[J].Kidney Int,2014,86(4):860-865.
4 Kang BH,Kikule K,Vialle-Valentin C,et al.TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors[J].BMB Rep,2012,45(1):1-6.
5 Im CN.Song HY,Meli M,et al.Past,present,and emerging roles of mitochondrial heat shock protein TRAP1 in the metabolism and regulation of cancer stem cells[J].Cell Stress Chaperones,2016,21(4):553-562.
6 Landriscina M,Amoroso MR,Piscazzi A,et al.Heat shock proteins,cell survival and drug resistance:the mitochondrial chaperone TRAP1,a potential novel target for ovarian cancer therapy[J].Gynecol Oncol,2010,117(2):177-182.
7 Amoroso MR,Matassa DS,Laudiero G,et al.TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins[J].Cell Death Differ,2012,19(4):592-604.
8 Yoo HJ,Im CN,Youn DY,et al.Bis is induced by oxidative stress via activation of HSF1[J].Physiol Pharmacol,2014,18(5):403-409.
9 Matassa DS,Amoroso MR,Maddalena F,et al.New insights into TRAP1 pathway[J].Am J Cancer Res,2012,2(2):235-248.
10 Altieri DC,Stein GS,Lian JB,et al.TRAP-1,the mitochondrial Hsp90[J].Biochim Biophys Acta,2012,1823(3):767-773.
11 Chae YC,Caino MC,Lisanti S,et al.Control of tumor bioenergetics and survival stress signaling by mitochondrial Hsp90s[J].Cancer Cell,2012,22(3):331-344.
12 李莉娜,史锐敏,王翠莲,等.胃癌组织中 TRAP1 的表达及意义[J].临床与实验病理学杂志,2015,31(3):323-325.
13 Han P,Wang QL,Zhang X,et al.Expression of TRAP1 in gastric cancer tissue and its correlation with malignant biology[J].Asian Pac J Trop Med,2016,9(1):67-71.
14 秦颖,张同先,张巍,等.青年乳腺癌临床病理特点分子分型及预后分析[J].中国肿瘤临床,2014,41(4):231-236.
15 Zhang B,Wang J,Huang Z,et al.Aberrantly upregulated TRAP1 is required for tumor igenesis of breast cancer[J].Oncotarget,2015,6(42):495-508.
16 Francesca M,Lorenza S,Giacomo L,et al.Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1[J].Molecular Oncology 2013,7(5):895-906.
17 Siegel R,Naishadham D,Jemal A,et al.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30.
18 Leav I,Janet P,Hira LG,et al.Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer[J].Am J Pathol,2010,176(1):393-401.
19 周亮,韩兆东,何慧婵,等.肿瘤坏死因子受体相关因子1蛋白在前列腺癌组织中的表达及意义[J].实用医学杂志,2014,29(19),3157-3159.
20 Luvero D,Milani A,Ledermann JA,et al.Treatment options in recurrent ovarian cancer:latest evidence and clinical potential[J].Ther Adv Med Oncol,2014,6(5):229-239.
21 Aust S,Bachmayr-Heyda A,Pateisky P,et al.Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer-a study of the OVCAD consortium[J].Mol Cancer,2012,11(2):69-75.
22 Ma RQ,Cheng HY,Ye X,et al.Expression and significance of tumor necrosis factor receptor associated protein 1 in epithelial ovarian cancer[J].J Peking Univ(Health Sci),2014,46(1):120-124.
23 Lv QJ,Sun HX,Cao CC,et al.Overexpression of tumor necrosis factor receptor-associated protein 1(TRAP1)are associated with poor prognosis of epithelial ovarian cancer[J].Tumor Biol,2016,37(2):2721-2727.
24 Matteo L,Maria R,Annamaria P,et al.shock proteins,cell survival and drug resistance:The mitochondrial chaperone TRAP1,a potential novel target for ovarian cancer therapy[J].Gynecologic Oncology,2010,117(2):177-182.
25 Kulendran M,Stebbing JF,Marks CG,et al.Predictive and prognostic factors in the complex treatment of patients with colorectal cancer[J].Magy Onkol,2010,54(4):383-394.
26 Gao JY,Song BR,Peng JJ,et al.Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer[J].World J Gastroenterol,2012,18(41):5965-5971.
27 Lettini G,GSisinni L,Condelli V,et al.TRAP1 regulates stemness through Wnt/beta-catenin pathway in human colorectal carcinoma[J].Cell Death Differ,2016,23(11):1792-1803.
28 Condelli V,Piscazzi A,Sisinni L,et al.TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell cycle progression:a novel target for BRAF-mutated colorectal tumors[J].Cancer Res,2014,74(22):6693-6704.
29 Li S,Lv QJ,Sun HX,et al.Expression of TRAP1 predicts poor survival of malignant glioma patients[J].J Mol Neurosci,2015,55(1):62-68.
30 Ostrom QT,Gittleman H,Liao P,et al.CBTRUS statistical report:Primary brain and central nervous system tumors diagnosed in the United States in 2007-2011[J].Neuro Oncology,2014,16(4):51-63.
31 Wu J,Liu Y,Cho K,et al.Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating metabolic reprogramming[J].Neuroreport,2016,27(3):136-144.
32 Tian X,Ma P,Sui CG,et al.Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer[J].FEBS J,2014,281(12):2805-2819.
33 Ou YW,Liu LY,Xue LY,et al.TRAP1 shows clinical signifi cance and promotes cellular migration and invasion through STAT3/MMP2 pathway in human esophageal squamous cell cancer[J].Genet Genomics,2014,41(10):529-537.
34 Lee JH,Kang KW,Kim JE,et al.Differential expression of heat shock protein 90 isoforms in small cell lung cancer[J].Int J Clin Exp Pathol,2015,8(8):9487-9493.
35 Si T,Yang G,Qiu X,et al.Expression of tumor necrosis factor receptor-associated protein 1 and its clinical significance in kidney cancer[J].Int J Clin Exp Pathol,2015,8(10):13090-13095.
36 Palladino G,Notarangelo T,Pannone G,et al.TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells[J].Endocr Relat Cancer,2016,23(9):699-709.

[1]	ZHANG Maoxiang,SUN Huixin,SONG Bingbing. Analysis of the incidence and mortality of malignant tumors in Daoli District,Harbin,2008—2012 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 261-265.
[2]	LIU Yishu,QU Guofan. Progress in long-chain non-coding RNA in osteosarcoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 266-270.
[3]	HOU Yuxue,LI Xiaoli. The research progress of Wnt7a and malignant tumors,and its relationship [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 271-275.
[4]	XU Hui, LI Xi, ZHOU Chunshui. Screening of lung cancer tumor-associated suppressor genes using shRNA library targeting human transcriptome [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 97-102.
[5]	YUAN Guixia, LI Yan, FENG Wanqi, XIA Xiaojuan, LI Xu. Mechanism of tumor suppressor gene DKK2 inhibiting proliferation of nephroblastoma cells in children [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 14-20.
[6]	DING Jiexian, ZHANG Jin, CHEN Yonggang, WANG Xingwen, WANG Shuanke. Progress in Wnt signaling pathway and tumorigenesis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 73-77.
[7]	YU Fang, ZHAO Pei. The role and mechanism of TRAP1 in the development of esophageal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 515-519.
[8]	KAN Jun, ZHOU Daihan, ZHANG Enxin. Research progress in tumor with cardiovascular disease [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 558-561.
[9]	LIU Juan, ZHANG Shutian. Advances in research on the mechanism of cyclin-dependent kinase inhibitor 3(CDKN3)in tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 575-578.
[10]	LI Yue, XU Ke, HAN Zengxiang, SUN Min, FAN Guohua, ZHANG Yong. Advances in the role of tumor-associated macrophage in colon cancer and targeted therapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 450-454.
[11]	WANG Yuan, SUN Yihua. Advance in the role of β-catenin in soft tissue tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 455-459.
[12]	ZHANG Yali, SU Danke. Research progress in gadolinium-based molecular probes for tumor targeting imaging [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 460-463.
[13]	HAN Bangling, WANG Yimin, XUE Yingwei. Research progress of vitamin D in tumors of digestive system [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 471-475.
[14]	HAN Bangling,WANG Yimin,XUE Yingwei. Research progress in the relationship between neutrophils and malignant tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 349-352.
[15]	ZHANG Yiyun,WU Huaxing. Progress of metabolic plasticity in tumor growth and metastasis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 362-366.

Research progress of the relationship between TRAP1 and malignant tumor

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments